v3.26.3
Fair Value of Financial Instruments - Nonrecurring Basis Measurements (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Aug. 31, 2026
Aug. 31, 2025
Aug. 31, 2026
Aug. 31, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Asset impairment and related expenses $ 49.8 $ 0.0 $ 68.1 $ 52.1
Impairment of equity method investments 0.0 1.5 0.0 1.5
Nonrecurring        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Asset impairment and related expenses     68.1 52.1
Impairment of equity method investments       1.5
Total       53.6
Quoted Prices in Active Markets (Level 1) | Nonrecurring        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Assets held for sale and related net assets 0.0 0.0 0.0 0.0
Equity method investments, fair value   0.0   0.0
Total   0.0   0.0
Significant Other Observable Inputs (Level 2) | Nonrecurring        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Assets held for sale and related net assets 5.0 0.0 5.0 0.0
Equity method investments, fair value   0.0   0.0
Total   0.0   0.0
Significant Unobservable Inputs (Level 3) | Nonrecurring        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Assets held for sale and related net assets $ 0.0 0.0 $ 0.0 0.0
Equity method investments, fair value   0.0   0.0
Total   $ 0.0   $ 0.0